MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans
Journal Article

Functional Screening of Parkinson’s Disease Susceptibility Genes to Identify Novel Modulators of α-Synuclein Neurotoxicity in Caenorhabditis elegans

2022
Request Book From Autostore and Choose the Collection Method
Overview
Idiopathic Parkinson’s disease (PD) is characterized by progressive loss of dopaminergic neurons during aging. The pathological hallmark of PD is the Lewy body detected in postmortem brain tissue, consisting largely of aggregated alpha-Synuclein (αSyn). However, an estimated 90 % of PD cases have unknown pathogenetic triggers. Here, we generated a new transgenic Caenorhabditis elegans PD model eraIs1 expressing GFP-based reporter of human αSyn in dopaminergic neurons and exhibits nice readout of developed alpha-Synuclein inclusions in dopaminergic neurons leading to their degeneration during aging. Using these animals in a preliminary reverse genetic screen of >100 PD GWAS-based susceptibility genes we identified together 28 C. elegans orthologs whose inactivation altered eraIs1 phenotype; 10 knockdowns exhibited reduced penetrance of formed αSyn::Venus inclusions in the axons of cephalic (CEP) dopaminergic neurons, 18 knockdowns exhibited increased penetrance of disrupted CEP dendrite integrity of which 9 knockdowns also exhibited disrupted neuronal morphology independently of expressed aSyn reporter. Loss-of-function alleles of the 5 identified genes, such as sac-2, rig-6 or lfe-2, unc-43 and nsf-1, modulated respective eraIs1 phenotypes, respectively, supporting the RNAi data. Western-blot analysis showed that insoluble αSyn::Venus levels do not correlate with the observed phenotypes in these mutants. However, the RNAi of 12 identified modulators reduced formation of pro-aggregating polyglutamine Q40::YFP foci in muscle cells suggesting the possible role of these genes in cellular proteotoxicity. The identified modulators through their associated biological pathways, such as calcium signaling or vesicular trafficking, thus represent new potential therapeutic targets for neurodegenerative proteopathies and other diseases associated with aging.